脊髓髓内肿瘤诊断与治疗的新进展(5)
[28] Lowe GM.Magnetic resonance imaging of intramedullary spinal cord tumors[J].J Neurooncol，2000，47(3)：195-210.
[29] Sandu N，Popperl G，Toubert ME，et al.Current molecular imaging of spinal tumors in clinical practice[J].Mol Med，2011，17(3-4)：308-316.
[30] Benedetto N，Aquila F，Vannozzi R.Use of near-infrared indocyanine videoangiography and flow 800 in the resectioning of a spinal cord haemangioblastoma[J].Br J Neurosurg，2013，27(6)：847-849.
[31] Harrop JS，Ganju A，Groff M，et al.Primary intramedullary tumors of the spinal cord[J].Spine(Phila Pa 1976)，2009，34(22 Suppl)：S69-S77.
[32] Karikari IO，Nimjee SM，Hodges TR，et al.Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors：a single-center experience with 102 patients[J].Neurosurgery，2011，68(1)：188-197.
[33] Isaacson SR.Radiation therapy and the management of intramedullary spinal cord tumors[J].J Neurooncol，2000，47(3)：231-238.
[34] Kahn J，Loeffler JS，Niemierko A，et al.Long-term outcomes of patients with spinal cord gliomas treated by modern conformal radiation techniques[J].Int J Radiat Oncol Biol Phys，2011，81(1)：232-238.
[35] Veeravagu A，Lieberson RE，Mener A，et al.CyberKnife stereotactic radiosurgery for the treatment of intramedullary spinal cord metastases[J].J Clin Neurosci，2012，19(9)：1273-1277.
[36] Kim WH，Yoon SH，Kim CY，et al.Temozolomide for malignant primary spinal cord glioma：an experience of six cases and a literature review[J].J Neurooncol，2011，101(2)：247-254.
[37] Chamberlain MC，Johnston SK.Recurrent spinal cord glioblastoma：salvage therapy with bevacizumab[J].J Neurooncol，2011，102(3)：427-432.
[38] Raco A，Esposito V，Lenzi J，et al.Long-term follow-up of intramedullary spinal cord tumors：a series of 202 cases[J].Neurosurgery，2005，56(5)：972-981.
[39] Kaley TJ，Mondesire-Crump I，Gavrilovic IT.Temozolomide or bevacizumab for spinal cord high-grade gliomas[J].J Neurooncol，2012，109 (2)：385-389.
[40] Chamberlain MC，Eaton KD，Fink J.Radiation-induced myelopathy：treatment with bevacizumab[J].Arch Neurol，2011，68(12)：1608-1609.
[41] Marsh JC，Goldfarb J，Shafman TD，et al.Current status of immunotherapy and gene therapy for high-grade gliomas[J].Cancer Control，2013， 20(1)：43-48.
[42] McCormick PC.Anatomic principles of intradural spinal surgery[J].Clin Neurosurg，1994，41：204-223.
[43] Cooper PR.Outcome after operative treatment of intramedullary spinal cord tumors in adults：intermediate and long-term results in 51 patients[J].Neurosurgery，1989，25(6)：855-859.
[44] Cohen AR，Wisoff JH，Allen JC，et al.Malignant astrocytomas of the spinal cord[J]. J Neurosurg，1989，70(1)：50-54.
(收稿日期：2014-03-18 本文编辑：许俊琴) (张伟强 陈春美)
[29] Sandu N，Popperl G，Toubert ME，et al.Current molecular imaging of spinal tumors in clinical practice[J].Mol Med，2011，17(3-4)：308-316.
[30] Benedetto N，Aquila F，Vannozzi R.Use of near-infrared indocyanine videoangiography and flow 800 in the resectioning of a spinal cord haemangioblastoma[J].Br J Neurosurg，2013，27(6)：847-849.
[31] Harrop JS，Ganju A，Groff M，et al.Primary intramedullary tumors of the spinal cord[J].Spine(Phila Pa 1976)，2009，34(22 Suppl)：S69-S77.
[32] Karikari IO，Nimjee SM，Hodges TR，et al.Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors：a single-center experience with 102 patients[J].Neurosurgery，2011，68(1)：188-197.
[33] Isaacson SR.Radiation therapy and the management of intramedullary spinal cord tumors[J].J Neurooncol，2000，47(3)：231-238.
[34] Kahn J，Loeffler JS，Niemierko A，et al.Long-term outcomes of patients with spinal cord gliomas treated by modern conformal radiation techniques[J].Int J Radiat Oncol Biol Phys，2011，81(1)：232-238.
[35] Veeravagu A，Lieberson RE，Mener A，et al.CyberKnife stereotactic radiosurgery for the treatment of intramedullary spinal cord metastases[J].J Clin Neurosci，2012，19(9)：1273-1277.
[36] Kim WH，Yoon SH，Kim CY，et al.Temozolomide for malignant primary spinal cord glioma：an experience of six cases and a literature review[J].J Neurooncol，2011，101(2)：247-254.
[37] Chamberlain MC，Johnston SK.Recurrent spinal cord glioblastoma：salvage therapy with bevacizumab[J].J Neurooncol，2011，102(3)：427-432.
[38] Raco A，Esposito V，Lenzi J，et al.Long-term follow-up of intramedullary spinal cord tumors：a series of 202 cases[J].Neurosurgery，2005，56(5)：972-981.
[39] Kaley TJ，Mondesire-Crump I，Gavrilovic IT.Temozolomide or bevacizumab for spinal cord high-grade gliomas[J].J Neurooncol，2012，109 (2)：385-389.
[40] Chamberlain MC，Eaton KD，Fink J.Radiation-induced myelopathy：treatment with bevacizumab[J].Arch Neurol，2011，68(12)：1608-1609.
[41] Marsh JC，Goldfarb J，Shafman TD，et al.Current status of immunotherapy and gene therapy for high-grade gliomas[J].Cancer Control，2013， 20(1)：43-48.
[42] McCormick PC.Anatomic principles of intradural spinal surgery[J].Clin Neurosurg，1994，41：204-223.
[43] Cooper PR.Outcome after operative treatment of intramedullary spinal cord tumors in adults：intermediate and long-term results in 51 patients[J].Neurosurgery，1989，25(6)：855-859.
[44] Cohen AR，Wisoff JH，Allen JC，et al.Malignant astrocytomas of the spinal cord[J]. J Neurosurg，1989，70(1)：50-54.
(收稿日期：2014-03-18 本文编辑：许俊琴) (张伟强 陈春美)